The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Glycosylation of immunoglobulin light chains in CAD
In this interview, Surbhi Sidana, MD, of the Mayo Clinic, Stanford, CA, discusses glycosylation of immunoglobulin as it relates to cold agglutinin disease (CAD) and how this can signify a risk for amyloidosis development. In this discussion, glycosylation is evaluated as a diagnostic tool for this indication. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
